Progranulin Regulates Inflammation And Tumor.

Antiinflamm Antiallergy Agents Med Chem 2019 Jul 24. Epub 2019 Jul 24.

Pathogenic Microbiology, Clinical Medical College, Weifang Medical University, Shandong 261053. China.

Background: Progranulin (PGRN) mediates cell cycle progression and cell motility as a pleiotropic growth factor and acts as a universal regulator of cell growth, migration and transformation, cell cycle, wound healing, tumorigenesis, and cytotoxic drug resistance as a secreted glycoprotein. PGRN overexpression can induce the secretion of many inflammatory cytokines, such as IL-8, -6,-10,TNF-α. At the same time, this protein can promote tumor proliferation and the occurrence and development of many related diseases such as gastric cancer, breast cancer, cervical cancer, colorectal cancer, renal injury, neurodegeneration, neuroinflammatory, human atherosclerotic plaque, hepatocarcinoma, acute kidney injury, amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease.

Conclusion: In short, PGRN plays a very critical role in injury repair and tumorigenesis, it provides a new direction for succeeding research and serves a target for clinical diagnosis and treatment, thus warranting further investigation. Here, we discuss the potential therapeutic utility and the effect of PGRN on the relationship between inflammation and cancer.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871523018666190724124214DOI Listing
July 2019
2 Reads

Publication Analysis

Top Keywords

cell cycle
8
cancer
5
injury neurodegeneration
4
neurodegeneration neuroinflammatory
4
renal injury
4
cancer renal
4
cancer colorectal
4
colorectal cancer
4
neuroinflammatory human
4
human atherosclerotic
4
kidney injury
4
injury amyotrophic
4
acute kidney
4
hepatocarcinoma acute
4
atherosclerotic plaque
4
plaque hepatocarcinoma
4
cervical cancer
4
cancer cervical
4
time protein
4
protein promote
4

Similar Publications